Tradewinds Capital Management’s Real Brokerage REAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.35K Hold
2,940
﹤0.01% 429
2025
Q4
$10.7K Hold
2,940
﹤0.01% 379
2025
Q3
$12.3K Hold
2,940
﹤0.01% 347
2025
Q2
$13.3K Hold
2,940
﹤0.01% 319
2025
Q1
$11.9K Hold
2,940
﹤0.01% 343
2024
Q4
$13.5K Hold
2,940
﹤0.01% 338
2024
Q3
$16.3K Hold
2,940
﹤0.01% 294
2024
Q2
$11.9K Hold
2,940
﹤0.01% 317
2024
Q1
$9.17K Hold
2,940
﹤0.01% 322
2023
Q4
$4.7K Hold
2,940
﹤0.01% 294
2023
Q3
$4.26K Hold
2,940
﹤0.01% 293
2023
Q2
$5.62K Hold
2,940
﹤0.01% 267
2023
Q1
$3.56K Hold
2,940
﹤0.01% 302
2022
Q4
$3.09K Hold
2,940
﹤0.01% 328
2022
Q3
$4K Hold
2,940
﹤0.01% 284
2022
Q2
$4K Hold
2,940
﹤0.01% 294
2022
Q1
$7K Hold
2,940
﹤0.01% 524
2021
Q4
$11K Hold
2,940
﹤0.01% 478
2021
Q3
$5K Hold
2,940
﹤0.01% 560
2021
Q2
$7K Buy
+2,940
New +$6.88K ﹤0.01% 532

Other funds holding REAX

Tradewinds Capital Management's REAX Position: Q1 2026 in Review

Tradewinds Capital Management held its Real Brokerage (REAX) position steady in Q1 2026 at 2,940 shares worth $7.35K. The position accounts for ﹤0.01% of the portfolio, ranked #429.

Tradewinds Capital Management first reported a position in REAX in Q2 2021 and has held it in 20 quarters since. The position peaked at $16.3K in Q3 2024. 159 funds tracked by Wall St. Rank hold REAX as of Q1 2026.

  • Tradewinds Capital Management held 2,940 shares of Real Brokerage worth $7.35K as of Q1 2026.
  • Tradewinds Capital Management left its Real Brokerage share count unchanged in Q1 2026.
  • Real Brokerage made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q1 2026, its #429 holding.
  • Tradewinds Capital Management first reported a position in Real Brokerage in Q2 2021 and has held it in 20 quarters since.
  • Tradewinds Capital Management's Real Brokerage position peaked at $16.3K in Q3 2024.
  • 159 funds tracked by Wall St. Rank held Real Brokerage as of Q1 2026.

Based on Tradewinds Capital Management's 13F filing for Q1 2026, filed 15 Apr 2026.